{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:07:54Z","timestamp":1769090874476,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.htct.2024.04.130","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T23:17:20Z","timestamp":1726183040000},"page":"S305-S308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S5","title":["Hemolytic anemia due to pyruvate kinase deficiency coexistent with the alpha thalassemia trait and chronic myeloid leukemia"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9284-2958","authenticated-orcid":false,"given":"Nirmal","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshit","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjith","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2024.04.130_bib0001","unstructured":"R. Hoffman, Ed., Hematology: Basic Principles and Practice, 7th ed.. Philadelphia, PA: Elsevier, 2018."},{"issue":"1","key":"10.1016\/j.htct.2024.04.130_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000206830","article-title":"Coexistence of \u03b1-thalassemia and a new pyruvate kinase variant: PK Fukien","volume":"69","author":"Beutler","year":"1983","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1016\/j.htct.2024.04.130_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajh.25325","article-title":"Addressing the diagnostic gaps in pyruvate kinase deficiency: consensus recommendations on the diagnosis of pyruvate kinase deficiency","volume":"94","author":"Bianchi","year":"2019","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.htct.2024.04.130_bib0004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000208980","article-title":"An unusual hematological syndrome with pyruvate-kinase deficiency and thalassemia minor in the kindreds","volume":"39","author":"Baughan","year":"1968","journal-title":"Acta Haematol"},{"issue":"4","key":"10.1016\/j.htct.2024.04.130_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-0609.1975.tb02424.x","article-title":"Haemolytic anaemia with hereditary pyruvate kinase instability developing acute leukaemia","volume":"14","author":"Goebel","year":"2009","journal-title":"Scand J Haematol"},{"issue":"3","key":"10.1016\/j.htct.2024.04.130_bib0006","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000207651","article-title":"Chronic myelomonocytic leukemia associated with hereditary pyruvate kinase deficiency and multiple acquired erythrocyte abnormalities","volume":"61","author":"Vives-Corrons","year":"1979","journal-title":"Acta Haematol"},{"issue":"10","key":"10.1016\/j.htct.2024.04.130_bib0007","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1902678","article-title":"Safety and efficacy of mitapivat in pyruvate kinase deficiency","volume":"381","author":"Grace","year":"2019","journal-title":"N Engl J Med"},{"issue":"10351","key":"10.1016\/j.htct.2024.04.130_bib0008","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(22)01337-X","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent \u03b1-thalassaemia or \u03b2-thalassaemia: an open-label, multicentre, phase 2 study","volume":"400","author":"Kuo","year":"2022","journal-title":"The Lancet"},{"issue":"Supplement 1","key":"10.1016\/j.htct.2024.04.130_bib0009","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1182\/blood-2022-163493","article-title":"Mitapivat improves markers of erythropoietic activity in long-term study of adults with alpha- or beta-non-transfusion-dependent thalassemia","volume":"140","author":"Kuo","year":"2022","journal-title":"Blood"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924003237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924003237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T06:11:32Z","timestamp":1732947092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137924003237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":9,"alternative-id":["S2531137924003237"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2024.04.130","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemolytic anemia due to pyruvate kinase deficiency coexistent with the alpha thalassemia trait and chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2024.04.130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}